Heavy Pharmaceuticals acquired a 51% stake in Chongqing Changsant Pharmaceutical Co., Ltd
-
Last Update: 2021-03-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Yesterday, Heavy Medicine Holdings announced that heavy medicine holding co., Ltd., a controlling subsidiary of heavy medicine shares on November 3, 2020, with Tiansan Pharmaceuticals signed the "Tiansheng Pharmaceutical Group Co., Ltd. Chongqing Pharmaceutical (Group) Co., Ltd. on Chongqing Changsan Pharmaceutical Co., Ltd." The equity transfer contract stipulates that heavy medicine shares will be purchased for 59.55 million yuan for a 51% stake in Changsan Pharmaceuticals held by Tiansan Pharmaceutical Co., Ltd. (excluding the 330m2 office building building of Chongqing Tiansan Pharmaceutical Co., Ltd. at 214 Tianzi Road, Wanzhou District).Upon completion of this transaction, Changssheng Pharma will become a subsidiary within the scope of the consolidated statements of listed companies. This transaction does not constitute an associated transaction, nor does it constitute a major asset reorganization as stipulated in the Measures for the Administration of Major Asset Reorganization of Listed Companies. (
of the heavy drug holding
)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
